| Abstract: | ![]()
The ultimate goal of regenerative medicine is the transplantation of a target organ generated by the patient's own cells. Recently, a method of organ generation using pluripotent stem cells (PSCs) and blastocyst complementation was reported. This approach is based on chimeric animal generation using an early embryo and PSCs, and the contribution of PSCs to the target organ is key to the method's success. However, the contribution rate of PSCs in target organs generated by different chimeric animal generation methods remains unknown. In this study, we used 8‐cell embryo aggregation, 8‐cell embryo injection, and blastocyst injection to generate interspecies chimeric mice using rat embryonic stem (ES) cells and then investigated the differences in the contribution rate of the rat ES cells. The rate of chimeric mouse generation was the highest using blastocyst injection, followed in order by 8‐cell embryo injection and 8‐cell embryo aggregation. However, the contribution rate of rat ES cells was the highest in chimeric neonates generated by 8‐cell embryo injection, and the difference was statistically significant in the liver. Live functionality was confirmed by analyzing the expression of rat hepatocyte‐derived drug‐metabolizing enzyme. Collectively, these findings indicate that the 8‐cell embryo injection method is the most suitable for generation of PSC‐derived organs via chimeric animal generation, particularly for the liver. |
